233 related articles for article (PubMed ID: 23606402)
21. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
22. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.
de Wit R; Roberts JT; Wilkinson PM; de Mulder PH; Mead GM; Fosså SD; Cook P; de Prijck L; Stenning S; Collette L
J Clin Oncol; 2001 Mar; 19(6):1629-40. PubMed ID: 11250991
[TBL] [Abstract][Full Text] [Related]
23. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
24. Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer.
Brabrand S; Fosså SD; Cvancarova M; Axcrona U; Lehne G
J Clin Oncol; 2012 Nov; 30(32):4004-10. PubMed ID: 23071246
[TBL] [Abstract][Full Text] [Related]
25. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
26. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
Li R; Li H
BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
[TBL] [Abstract][Full Text] [Related]
27. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy for metastatic germ cell tumours of the testis].
Culine S
Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
[TBL] [Abstract][Full Text] [Related]
29. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
30. Testicular germ cell tumours.
Horwich A; Nicol D; Huddart R
BMJ; 2013 Sep; 347():f5526. PubMed ID: 24065428
[No Abstract] [Full Text] [Related]
31. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
32. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
Suarez-Ibarrola R; Abufaraj M; Shariat SF
Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
[TBL] [Abstract][Full Text] [Related]
34. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
35. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
[TBL] [Abstract][Full Text] [Related]
36. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
37. Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
Karim S; Wei X; Leveridge MJ; Siemens DR; Robinson AG; Bedard PL; Booth CM
Urol Oncol; 2019 Mar; 37(3):183.e17-183.e24. PubMed ID: 30478011
[TBL] [Abstract][Full Text] [Related]
38. First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database.
Oing C; Lorch A; Bokemeyer C; Honecker F; Beyer J; Berger LA; Oechsle K
J Cancer Res Clin Oncol; 2015 May; 141(5):923-31. PubMed ID: 25395217
[TBL] [Abstract][Full Text] [Related]
39. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Bokemeyer C; Nichols CR; Droz JP; Schmoll HJ; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Hartmann JT
J Clin Oncol; 2002 Apr; 20(7):1864-73. PubMed ID: 11919246
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first-line chemotherapy from a tertiary cancer center in India.
Joshi A; Zanwar S; Shetty N; Patil V; Noronha V; Bakshi G; Prakash G; Menon S; Prabhash K
Indian J Cancer; 2016; 53(2):313-316. PubMed ID: 28071636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
